Welcome to our dedicated page for Gentherm news (Ticker: THRM), a resource for investors and traders seeking the latest updates and insights on Gentherm stock.
Gentherm Inc. reports developments in thermal management and pneumatic comfort technologies for automotive and medical markets. Its Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, Valve Systems, cable systems, battery performance solutions, and automotive electronics and software systems. Its Medical business covers patient temperature management systems and related device technology.
Recurring news includes quarterly and annual results, conference participation, automotive new-business activity, shareholder voting matters, and medical-device regulatory updates. Company announcements also cover ThermAffyx™ Patient Safety System, an integrated patient warming and securement system submitted through the FDA 510(k) pathway, and communications activity around Gentherm Medical products.
Gentherm, a global leader in thermal management technologies, won the 2024 Automotive News PACE Innovation Partnership Award for developing ClimateSense with General Motors. This award recognizes collaboration in bringing cutting-edge technology to the automotive industry. Gentherm's ClimateSense will be featured in the 2024 Cadillac CELESTIQ, showcasing energy savings and optimal comfort. The PACE Awards ceremony took place in Detroit, celebrating innovation in automotive technology.
Gentherm reported its 2024 first quarter financial results, highlighting a 86% increase in net income year over year and $530M in automotive new business awards. The company's product revenues decreased slightly, with automotive revenues also showing a slight decline. However, the company's CEO expressed confidence in strong demand for its solutions and profitability improvements through cost-saving initiatives. Gentherm reaffirmed its 2024 guidance and remains optimistic about revenue growth and margin expansion.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.